EP3283566A1 - Formulation - Google Patents

Formulation

Info

Publication number
EP3283566A1
EP3283566A1 EP15720921.4A EP15720921A EP3283566A1 EP 3283566 A1 EP3283566 A1 EP 3283566A1 EP 15720921 A EP15720921 A EP 15720921A EP 3283566 A1 EP3283566 A1 EP 3283566A1
Authority
EP
European Patent Office
Prior art keywords
formulation
high density
density polyethylene
ppm
slip agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15720921.4A
Other languages
German (de)
English (en)
Inventor
Bruno Nabeth
Iwan MEIER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Obrist Closures Switzerland GmbH
Original Assignee
Obrist Closures Switzerland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obrist Closures Switzerland GmbH filed Critical Obrist Closures Switzerland GmbH
Publication of EP3283566A1 publication Critical patent/EP3283566A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04—Homopolymers or copolymers of ethene
    • C08L23/06—Polyethene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0083—Nucleating agents promoting the crystallisation of the polymer matrix
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2207/00—Properties characterising the ingredient of the composition
    • C08L2207/06—Properties of polyethylene
    • C08L2207/062—HDPE

Definitions

  • the present invention relates to an improved high density polyethylene (HDPE) formulation and in particular, but not exclusively, to formulations for the manufacture of caps and closures, for example screw caps for drink containers.
  • the present invention also relates to caps and closures manufactured from an improved high density polyethylene (HDPE) formulations, and the manufacture and uses thereof.
  • thermoplastic polymer melt cools and during cooling spontaneous homogenous nucleation occurs to provide lamellae.
  • the lamellae continue to grow to provide a complex macrostructure comprising spherulites within the thermoplastic polymer.
  • the nucleation and the subsequent crystal growth is highly dependent on the temperature of the polymer melt and on the type of thermoplastic polymer. It has also been found that the number and size of the spherulites within the macrostructure has an importance influence over a number of physical and optical properties of the resultant thermoplastic polymer based item.
  • the size of the spherulites within the polymer is dependent on the number of nucleation sites within the thermoplastic polymer melt, on the temperature of the melt at nucleation, on the speed of cooling, on the speed of nucleation sites formation compared to speed of growth those crystalline microstructure.
  • the presence of a nucleating agent for heterogeneous crystallization within the melt can help to increase the rate of crystallization of a thermoplastic polymer melt, and therefore have a direct influence on the number and size of the spherulites within the polymer.
  • a number of studies have been carried out in relation to the use of nucleating agents for the heterogeneous crystallisation of polymers which are not high density polymers such thermoplastic polymers which have a low rate of crystallization, e.g.
  • High density polyethylene readily crystalizes so the present invention seeks to overcome difficulties with producing high density polyethylene for caps or closures so they can be manufactured to have one or more of: improved stiffness, improved opening force behaviour, improved shrinkage, improved shrinkage according to colors, improved warpage, reduced defects and/or reduction of blooming effect compared to conventional high density polyethylene caps or closures.
  • the present invention also provides a method of manufacturing high density polyethylene caps and closures with reduced associated cycle time compared to conventional methods of manufacturing high density polyethylene caps.
  • the present invention provides a high density polyethylene (HDPE) formulation comprising: high density polyethylene (HDPE) and one or more nucleating agents.
  • HDPE high density polyethylene
  • the term 'high density polyethylene' is used herein to refer to polyethylene having a density of at least 940 kg/m 3 .
  • the high density polyethylene has a density of no more than 970 kg/m 3 .
  • the high density polyethylene has a density of at least 945 kg/m 3 , more preferably at least 950 kg/m 3 .
  • the high density polyethylene has a density of no more than 965 kg/m 3 , more preferably no more than 960 kg/m 3 .
  • the high density polyethylene may comprise a blend of two or more high density polyethylene fractions, each fraction having different densities.
  • the nucleating agent may be any suitable substance, or mixture of substances, that forms nuclei or provides nucleation sites for the formation and/or growth of crystals in high density polyethylene as it solidifies from a molten state.
  • the nucleating agent may be any suitable substance(s) that raises the crystallization temperature of the high density polyethylene composition.
  • the nucleating agent may be any suitable substance(s) that is capable of changing the orientation of crystalline lamellae and/or modifying the crystal size of high density polyethylene.
  • High density polyethylene has a high rate of homogeneous nucleation.
  • the nucleating agent may be any suitable substance(s) that is capable of enabling heterogeneous nucleation within the melt prior to homogeneous nucleation of the high density polyethylene.
  • the nucleating agent may comprise one or more soluble nucleating agents which are capable of dissolving in the molten polymer, in particular in molten high density polyethylene.
  • the nucleating agent may comprise one or more insoluble nucleating agents which are not capable of dissolving in the molten polymer, in particular in molten high density polyethylene.
  • the nucleating agent may comprise a combination of soluble and insoluble nucleating agents.
  • Soluble nucleating agent(s) may include, but are not limited to, one or more of: acetal compounds that are the condensation product of a polyhydric alcohol and an aromatic aldehyde, including for example sorbitol acetals.
  • the sorbitol acetals may include dibenzylidene sorbitol (DBS), bis (p-methyl- dibenzylidene sorbitol) (MDBS), bis(3,4-dimethyl-dibenzylidene sorbitol) (DMDBS), and derivatives thereof.
  • DBS dibenzylidene sorbitol
  • MDBS bis (p-methyl- dibenzylidene sorbitol)
  • DDBS bis(3,4-dimethyl-dibenzylidene sorbitol)
  • Further soluble nucleating agent(s) may include triamide nucleating agents and polymeric nucleating agents
  • Insoluble nucleating agent(s) may include, but are not limited to, one or more of: mineral based nucleating agents (such as for example talc, mica, kaolin, and halloysite), organic acid salts such as alkali metal salts or organic acids and alkaline earth metal salts or organic acids, transition metal salts or organic acids and post-transition metal salts of organic acids, or any combination thereof.
  • the alkali metal salts are preferably lithium, sodium or potassium salts.
  • the alkaline earth metal salts are preferably magnesium or calcium salts.
  • the transition metal salts are preferably manganese or zinc salts.
  • the post-transition metal salts are preferably aluminium salts.
  • suitable nucleating agents include, but are not limited to, aliphatic or aromatic salts, such as benzoic acid salts, phosphate ester salts (such as for example bisphenol phosphate ester salts), carboxylate salts, benzenesulfonic acid salts, mandelic acid salts, and combinations thereof.
  • suitable carboxylate salts may include may organocarboxylic acid salts, such as alicyclic organocarboxylic acid salts and bicyclic organodicarboxylic acid salts.
  • suitable carboxylate salts preferably include bicyclic alkane dicarboxylate salts (such as for example disodium bicycle(2.2.1 )heptane-2,3-dicarboxylate and calcium bicycle[2.2.
  • the carboxylate salts include hexahydrophthalic acid, calcium salt (Hyperform® HPN-20E), sodium salt (Hyperform® HPN-68L), Hyperform ® being a zinc stearate and cyclohexanedicarboxylic acid, calcium salt.
  • nucleating agents examples include: 12H-Dibenzo[d, g] [ 1 ,3,2] dioxaphophocin, 2, 4, 8, 10-tetrakis ( l , l -dimethylethyl)-6-hydroxy-6-oxide, sodium salt (ADK STAB NAI l -UH); ADK STAB NA21 ; ADK STAB NA7I ; Hyperform® HPN-68L; and any combination thereof.
  • the nucleating agent is selected from one or more of Hyperform® HPN-20E, ADK STAB NAI l -UH, ADK STAB NA2 I ; ADK STAB NA7 I , and Hyperform® HPN-68L, and any combination thereof.
  • the concentration of the nucleating agent(s) in the formulation will depend on the particular crystallization efficiency of the agent(s).
  • the nucleating agents are preferably present within the formulation in an amount sufficient to initiate heterogeneous recrystallization of the high density polypropylene.
  • the nucleating agent(s) is preferably present within the formulation at a concentration of at least 50 ppm, more preferably at least 75 ppm, for example at least about I OOppm.
  • the nucleating agent(s) is preferably present within the formulation at a concentration of no more than 800 ppm, more preferably no more than 500 ppm, for example no more than 250 ppm.
  • the nucleating agent(s) is preferably present within the formulation at a concentration within the range of 50 ppm and 800 ppm; more preferably within the range of 100 ppm and 250 ppm.
  • the nucleating agent(s) is present within the formulation at a concentration of about 150 ppm.
  • the present invention provides a cap or closure comprising a high density polyethylene formulation comprising high density polyethylene (HDPE) and one or more nucleating agents.
  • the cap or closure of the present invention preferably includes, but is not limited to, screw caps, caps and closures with a living hinge, transparent caps and closures, glossy caps and closures.
  • the cap or closure is a screw cap.
  • the caps and closures of the present invention may be used in various packaging applications, including for example food packaging, medical packaging, cosmetic packaging, detergent packaging.
  • the cap or closure is a cap or closure of a drink container, such as for example a carbonated or still drink container.
  • the present invention provides a method for the manufacture of a HDPE formulation as herein described, the method comprising:
  • nucleating agent(s) introducing one or more nucleating agents to high density polyethylene to provide a high density polyethylene formulation, in which the nucleating agent(s) is present within the formulation at a concentration sufficient to initiate heterogeneous crystallisation of the high density polyethylene.
  • the present invention provides a method for the manufacture of a cap or closure comprising:
  • nucleating agents to high density polyethylene to provide a high density polyethylene formulation, in which the nucleating agent(s) is present within the formulation at a concentration sufficient to initiate heterogeneous crystallisation of the high density polyethylene; and shaping the high density polyethylene formulation to provide the cap or closure.
  • the method involves shaping the formulation by injection molding.
  • the method of manufacturing the caps or closures according to the present invention has improved efficiency compared to conventional methods of manufacturing HDPE caps or closures.
  • the method of the present invention has improved efficiency due to the efficient nucleation generated by the presence of the nucleating agent(s) within the HDPE formulation.
  • Cycle time reduction is also achieved as a result of inducing in the high density polyethylene melt a higher temperature of crystallisation which enables the molten polymer melt to harden at a higher temperature.
  • the cooling time for the HDPE formulation is reduced compared to HDPE and the resultant caps or closures can be removed from the mold at a faster rate than would be possible without the presence of the nucleating agent(s).
  • the cycle time of the method of manufacture of the caps or closures of the present invention is reduced by at least 5%, more preferably at least 10%, compared to conventional methods of manufacturing HDPE caps or closures.
  • the presence of the nucleating agent(s) within the formulation also increases the demoulding temperature of the cap or closure.
  • the cap or closure manufactured from a formulation comprising HDPE and a nucleating agent(s) is more robust and less likely to demonstrate quality issues, associated with for example broken bridges during demolding.
  • the present invention also provides a HDPE cap or closure with improved functional performance compared to conventional HDPE caps or closures. Furthermore, the HDPE cap or closure of the present invention has a controlled opening torque in an acceptable range, such as for example.
  • the HDPE cap or closure of the present invention has also been found to have improved stiffness compared to conventional HDPE caps or closures. As a result, the HDPE cap or closures of the present invention provide a reduced blooming effect, and as such are suitable for use with pressurised containers, such as for example carbonated drink containers.
  • the present invention provides a HDPE formulation comprising: high density polyethylene (HDPE);
  • the slip agent formulation preferably comprises: at least one of an unsaturated slip agent and/or a saturated slip agent, or any combination thereof.
  • the slip agent formulation preferably further comprises at least one of:
  • At least one process stabiliser At least one process stabiliser
  • At least one secondary antioxidant at least one secondary antioxidant
  • the slip agent may comprise any suitable conventional slip agent such as for example aliphatic saturated and/or unsaturated fatty acid containing between 16 and 22 carbon atoms.
  • the slip agent(s) may comprise one or more primary fatty acid amides, including for example erucamide, behenamide and oleamide; and/or one or more secondary fatty acid amides, including for example stearyl erucamide, oleyl palmitamide, erucyl erucamide and stearyl stearamide; and/or one or more branched fatty acid amides; and/or one or more saturated bis amides, including for example ethylene bid stearamide.
  • the slip agent(s) comprises erucamide ( 13-cis-docosenamide) and/or behanamide.
  • the slip agent comprises erucamide.
  • the slip agent may be present at any suitable concentration within the slip agent formulation.
  • the saturated and unsaturated slip agent are preferably each present within the slip agent formulation at a concentration in the range of between 0 and 3000 ppm.
  • the or each of the saturated and/or unsaturated slip agent are present within the slip agent formulation at a concentration of at least 50 ppm, preferably at least 500 ppm, more preferably at least 1000 ppm, or for example at least 1500 ppm.
  • the or each of the saturated and/or unsaturated slip agent are present within the slip agent formulation at a concentration of at no more than 3000 ppm, more preferably no more than 2750 ppm, for example no more than 2500 ppm.
  • the or each of the saturated and/or unsaturated slip agent may be present within the formulation at a concentration within the range of between 500 ppm and 2500 ppm, for example between 1000 ppm and 2500 ppm, I OOOppm to 2000ppm, or between 1800 ppm and 2200 ppm.
  • the or each of the saturated and/or unsaturated slip agent may, for example, be present within the formulation at a concentration of approximately I OOOppm or 2000 ppm.
  • the filler may comprise any number of suitable fillers for the slip agent formulation.
  • the filler may comprise one or more of calcium stearate and/or zinc stearate.
  • the filler comprises calcium stearate.
  • the filler may be present within the formulation at any suitable concentration.
  • the total filler concentration within the slip agent formulation is preferably at least 100 ppm, more preferably at least 250 ppm, or for example at least 500 ppm.
  • the total filler concentration in the slip agent formulation is preferably no more than 2500 ppm, more preferably no more than 2200 ppm.
  • the total filler concentration in the slip agent formulation is preferably in the range of 500 to 2500, more preferably between 1000 ppm and 2500 ppm, especially preferably between 1800 ppm and 2200 ppm, for example 2000 ppm.
  • the stabiliser may comprise any suitable process stabiliser or combination of process stabilisers.
  • the stabiliser is preferably a heat stabiliser.
  • the stabiliser may comprise tris(2,4-di-tert- butylphenyl)phosphite (Irgafos 168) or use another to describe a solution that we do not use.
  • the slip agent formulation preferably comprises a total stabiliser concentration of no more than 1000 ppm, preferably no more than 900 ppm, for example no more than 660 ppm.
  • the slip agent formulation preferably comprises a total stabiliser concentration of at least 200 ppm, preferably at least 250 ppm, more preferably at least 540 ppm.
  • the total stabiliser concentration is preferably in the range of between 200 ppm and 1000 ppm, more preferably in the range of between 250 ppm and 1000 ppm, more preferably in the range of from 200 ppm to 900 ppm, especially preferably in the range of from 540 ppm to 660 ppm.
  • the total stabiliser concentration is preferably about 600 ppm.
  • the primary antioxidant preferably comprises any suitable antioxidant, or combination of antioxidants, capable of providing processing and long term thermal stabilization of the formulation.
  • the primary antioxidant comprises at least one phenolic antioxidant.
  • the primary antioxidant preferably comprises Octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate (Irganox 1076).
  • Irganox 1076 Octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate
  • the slip agent formulation preferably comprises a total primary antioxidant concentration of no more than 150 ppm, and more preferably no more than I 10 ppm.
  • the slip agent formulation preferably comprises a total primary antioxidant concentration of at least 30 ppm, more preferably at least about 50 ppm, for example at least about 90 ppm.
  • the slip agent formulation preferably comprises a total primary antioxidant concentration in the range of between 30 ppm and 150 ppm, preferably in the range of from 50 ppm and 150 ppm, especially preferably in the range of between 90 ppm and I 10 ppm, for example 100 ppm.
  • the secondary antioxidant may be any suitable antioxidant, or combination of antioxidants, for providing light protection, low volatility and minimal migration of the slip agent formulation.
  • the secondary antioxidant may be any suitable antioxidant further providing long term heat stability of the slip agent formulation.
  • the secondary antioxidant preferably comprises butanedioic acid, dimethylester, polymer with 4-hydroxy-2,2,6,6-tatramethyl- l -piperidine ethanol (Tinuvin 622 LD).
  • the secondary antioxidant may be present at any suitable concentrations within the slip agent formulation to provide the necessary protection discussed above.
  • the slip agent formulation preferably comprises a total secondary antioxidant concentration of up to 1500 ppm, preferably up to 1000 ppm, more preferably up to 800 ppm, for example up to 550 ppm.
  • the slip agent formulation preferably comprises a total secondary antioxidant concentration of at least 300 ppm, more preferably at least 450 ppm.
  • the slip agent formulation preferably comprises a total secondary antioxidant concentration of between 300 ppm and 1500 ppm, more preferably between 300 ppm and 800 ppm, especially preferably between 450 and 550 ppm, for example 500 ppm.
  • the slip agent formulation may comprise any suitable UV absorber, or combination of UV absorbers.
  • the slip agent formulation may comprise 2-(5-chloro(2H)-benzotrazole-2-yl)-4-methyl-6- (tert-butyl)phenol (Tinuvin 326).
  • the slip agent formulation may comprise a total concentration of UV absorber of up to 900 ppm, more preferably up to 800 ppm, for example of up to 550 ppm.
  • the slip agent formulation may comprise a total UV absorber concentration of at least 200 ppm, more preferably at least 450 ppm.
  • the slip agent formulation preferably comprises a total UV absorber concentration in the range of between 200 ppm and 900 ppm, more preferably between 200 ppm and 800 ppm; especially preferably in the range of between 450 and 550 ppm, for example 500 ppm.
  • the slip agent formulation preferably comprises:
  • a slip agent selected from erucamide and/or behenamide and/or IncroslipTM SL or any combination thereof, and at least one of:
  • At least one filler selected from: calcium stearate and/or zinc stearate, or any combination thereof;
  • a process stabiliser comprising tris(2,4-di-tert-butylphenyl)phosphite (Irgafos 168);
  • a primary antioxidant comprising octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate (Irganox 1076); a secondary antioxidant selected from butanedioic acid, dimethylester, polymer with 4- hydroxy-2,2,6,6-tetramethyl- l -piperidine ethanol (Tinuvin 622); and
  • a UV absorber comprising 2-(5-chloro(2H)-benzotrazole-2-yl)-4-(methyl)-6-(tert-butyl)phenol (Tinuvin 326).
  • the slip agent is erucamide and behenamide or IncroslipTM SL (a slip agent and torque release agent.).
  • the slip agent formulation comprises erucamide.
  • the present invention provides a cap or closure comprising a high density polyethylene formulation comprising high density polyethylene (HDPE), at least one nucleating agents, and a slip agent formulation.
  • HDPE high density polyethylene
  • the cap or closure preferably includes, but is not limited to, screw caps, caps and closures with a living hinge, transparent caps and closures, glossy caps and closures.
  • the cap or closure is a screw cap.
  • the present invention provides a method for the manufacture of a HDPE formulation as herein described, the method comprising:
  • nucleating agent introducing at least one nucleating agent, and a slip agent formulation, to high density polyethylene to provide a high density polyethylene formulation, in which the nucleating agent(s) is present within the formulation at a concentration sufficient to initiate heterogeneous crystallisation of the high density polyethylene.
  • the present invention provides a kit for the manufacture of a HDPE formulation as herein described, the kit comprising:
  • first container comprising high density polyethylene
  • second container comprising at least one nucleating agent
  • first and second containers may additionally comprise the slip agent formulation.
  • first container may comprise the slip agent formulation.
  • second container may comprise the slip agent formulation.
  • the present invention provides a kit for the manufacture of a HDPE formulation as herein described, the kit comprising:
  • first container comprising high density polyethylene and at least one nucleating agent
  • second container comprising a slip agent formulation
  • the contents of the second container i.e. the nucleating agent and optionally the slip agent formulation
  • the caps or closures of the present invention are preferably screw caps.
  • the cap or closure of the present invention may be formed by any suitable method. According to a still further aspect, the present invention provides a method for the manufacture of HDPE caps or closures as herein described, the method comprising:
  • nucleating agent introducing at least one nucleating agent and a slip agent formulation, to high density polyethylene to provide a high density polyethylene formulation, in which the nucleating agent(s) is present within the formulation at a concentration sufficient to initiate heterogeneous crystallisation of the high density polyethylene;
  • the at least one nucleating agent and slip agent formulation may be introduced simultaneously or separately to the high density polyethylene.
  • the present invention provides HDPE caps and closures with excellent slip properties. Furthermore, the present invention provides HDPE caps and closures with increased UV protection. In particular, the present invention provides HDPE caps and closures with low, preferably substantially no, UV degradation. Furthermore, the nucleating agent(s), and optionally the slip agent formulation, do not impart any undesirable taste into the HDPE article, such as caps or closures.
  • the HDPE caps or closures prepared according to the methods of the present invention exhibit higher stiffness and good opening force behaviour.
  • the cycle time for the production of HDPE caps or closures using an HDPE formulation comprising nucleating agent(s) and slip agent formulation is reduced by preferably at least 10%, more preferably at least 15%, for example at least 20% when compared to the cycle time for production of HDPE caps or closures using HDPE prepared using homogeneous crystallization.
  • the cycle time for the production of HDPE caps or closures using an HDPE formulation comprising nucleating agent(s) and slip agent formulation is reduced by between 12 and 20% compared to the cycle time for production of HDPE caps or closures using HDPE prepared using homogeneous crystallization.
  • the cycle time for the production of the HDPE caps or closures of the present invention using a HDPE formulation comprising nucleating agent(s) and slip agent formulation is significantly reduced compared to the cycle time associated with the production of HDPE caps or closures using HDPE formulations comprising nucleating agent(s) alone.
  • the cycle time for the production of HDPE caps or closures using an HDPE formulation comprising nucleating agent(s) and slip agent formulation is reduced by at least 5%, preferably at least 10% when compared to the cycle time for production of HDPE caps or closures using HDPE formulations comprising nucleating agent(s) alone.
  • the present invention relates to PEHD and a nucleating agent, with or without a slip agent package.
  • the improved efficiency of nucleating agent leads to an increase of demoulding temperature associated with a better resistance of frangible tamper-evident bridges which leads to:
  • the invention may comprise a PEHD formulation including:
  • a nucleating agent typically Calcium, Lithium, Sodium, Aluminium salt (aliphatic or aromatic) in a content between 50 and 800 ppm (especially between 100 and 250 ppm); and
  • An additive package including an unsaturated slip agent (for example Erucamide) associated with UV stabilizer and other additives like antistatic, heat stabilizer, anti-oxidant.
  • unsaturated slip agent for example Erucamide
  • UV stabilizer for example UV stabilizer
  • other additives like antistatic, heat stabilizer, anti-oxidant.
  • the use of the combination can be done in different ways, for example:
  • the invention consists in caps injected in PEHD.
  • the composition of PEHD may use :
  • the additive package provides, for example, on beverage screw caps, excellent slip properties and UV protection (no UV degradation and not creating off-taste).
  • the high density polyethylene formulation comprises high density polyethylene and Hyperform ® HPN- 20E as the nucleating agent.
  • Hydroform ® HPN-20E is present at within the HDPE formulation at a concentration of 150 ppm.
  • the high density polyethylene formulation was used to manufacture a cap by injection molding.
  • the cycle time for producing the cap was reduced by 10% compared to conventional processes for manufacturing caps using HDPE formed by homogeneous crystallization.
  • Example 2 High Density Polyethylene Formulation with Nucleating Agent and Slip Agent Formulation
  • the high density polyethylene formulation comprises:
  • Hyperform ® HPN-20E as the nucleating agent. Hydroform ® HPN-20E is present at within the HDPE formulation at a concentration of 150 ppm;
  • a slip agent formulation comprising:
  • slip agent comprising erucamide and behenamide.
  • the total concentration of slip agent present within the slip agent formulation at a concentration of 2000 ppm;
  • a filler comprising calcium stearate at a concentration of 2000 ppm within the slip agent formulation
  • a process stabiliser comprising tris(2,4-di-tert-butylphenyl)phosphite, the concentration of stabiliser within the slip agent formulation is 600 ppm;
  • a primary antioxidant comprising octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, and the total concentration of primary antioxidant within the formulation is 100 ppm;
  • a secondary antioxidant comprising butanedioic acid dimethylester polymer with 4-hydroxy- 2,2,6,6-tetramethyl- 1 -piperidine ethanol, and the total concentration of secondary antioxidant within the formulation is 500 ppm;
  • Example 3 High Density Polyethylene Formulation with Nucleating Agent and Slip Agent Formulation
  • the high density polyethylene formulation comprises:
  • Hyperform ® HPN-20E as the nucleating agent. Hydroform ® HPN-20E is present at within the HDPE formulation at a concentration of 150 ppm;
  • a slip agent formulation comprising: a slip agent comprising IncroslipTM SL.
  • a filler comprising calcium stearate at a concentration of 2000 ppm within the slip agent formulation
  • a process stabiliser comprising tris(2,4-di-tert-butylphenyl)phosphite, the concentration of stabiliser within the slip agent formulation is 600 ppm;
  • a primary antioxidant comprising octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, and the total concentration of primary antioxidant within the formulation is 100 ppm;
  • a secondary antioxidant comprising butanedioic acid dimethylester polymer with 4-hydroxy- 2,2,6,6-tetramethyl- 1 -piperidine ethanol, and the total concentration of secondary antioxidant within the formulation is 500 ppm;
  • a UV absorber comprising 2-(5-chloro(2H)-benzotrazole-2-yl)-4-(methyl)-6-(tert-butyl)phenol, and the total concentration of UV absorber within the formulation is 500 ppm.
  • the high density polyethylene formulation was used to manufacture a cap by injection molding.
  • the cycle time for producing the cap was reduced by 20% compared to conventional processes for manufacturing caps using HDPE formed by homogeneous crystallization. This cycle time reduction is far greater than the cycle time reduction provided by HDPE formulations comprising nucleating alone, as demonstrated in Example I .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La présente invention concerne une formulation de polyéthylène haute densité (HDPE) comprenant : un polyéthylène haute densité (HDPE) et un ou plusieurs agents de nucléation.
EP15720921.4A 2015-04-17 2015-04-17 Formulation Withdrawn EP3283566A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2015/058384 WO2016165773A1 (fr) 2015-04-17 2015-04-17 Formulation

Publications (1)

Publication Number Publication Date
EP3283566A1 true EP3283566A1 (fr) 2018-02-21

Family

ID=53055007

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15720921.4A Withdrawn EP3283566A1 (fr) 2015-04-17 2015-04-17 Formulation

Country Status (2)

Country Link
EP (1) EP3283566A1 (fr)
WO (1) WO2016165773A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053411A1 (fr) * 2019-09-20 2021-03-25 Sabic Global Technologies B.V. Polyéthylène haute densité à transparence accrue

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3448926B1 (fr) 2016-08-26 2019-10-09 Total Research & Technology Feluy Capuchons ou bouchons fabriqués à partir d'une composition de résine contenant du polyéthylène
KR101742446B1 (ko) * 2016-12-06 2017-06-15 한화토탈 주식회사 병뚜껑용 폴리에틸렌 수지 조성물 및 이로부터 제조된 성형품
CN114316530B (zh) * 2021-12-30 2023-04-07 康辉新材料科技有限公司 一类耐热聚丁二酸丁二醇酯组合物、成核剂及其制备方法
CN114921063B (zh) * 2021-12-30 2023-05-09 康辉新材料科技有限公司 一类耐热聚对苯二甲酸-己二酸-丁二醇酯/聚乳酸组合物、成核剂及其制备方法
CN114921062B (zh) * 2021-12-30 2023-05-09 康辉新材料科技有限公司 一类耐热热塑性聚酯组合物、成核剂及其制备方法
CN114507425B (zh) * 2021-12-30 2023-06-16 康辉新材料科技有限公司 一类耐热聚乳酸组合物、聚乳酸成核剂及其制备方法
CN114921064B (zh) * 2021-12-30 2023-05-09 康辉新材料科技有限公司 一类耐热聚对苯二甲酸-己二酸-丁二醇酯组合物、成核剂及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110300391A1 (en) * 2010-06-08 2011-12-08 Haley Jeffrey C Multilayer films having reduced curling
EP2402391A1 (fr) * 2010-06-29 2012-01-04 Borealis AG Composition de polyéthylène bimodale pour articles moulés par injection
US8809433B2 (en) * 2007-03-14 2014-08-19 Equistar Chemicals, Lp Barrier properties of substantially linear HDPE film with nucleating agents
US20140287215A1 (en) * 2013-03-25 2014-09-25 Dow Global Technologies Llc Film having good barrier properties together with good physical characteristics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013052273A2 (fr) * 2011-10-04 2013-04-11 Exxonmobil Chemical Patents Inc. Utilisation de la température et de la pression partielle d'éthylène pour introduire des ramifications à longue chaîne dans un polyéthylène haute densité
AU2014286957A1 (en) * 2013-07-12 2016-01-21 Berry Plastics Corporation Polymeric material for container
TW201521993A (zh) * 2013-08-30 2015-06-16 Berry Plastics Corp 用於容器之聚合材料
CN104004253B (zh) * 2014-05-12 2016-09-14 漯河科莱堡洁具配件有限公司 高分子量聚合物成核剂改性超高分子量聚乙烯共混材料

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809433B2 (en) * 2007-03-14 2014-08-19 Equistar Chemicals, Lp Barrier properties of substantially linear HDPE film with nucleating agents
US20110300391A1 (en) * 2010-06-08 2011-12-08 Haley Jeffrey C Multilayer films having reduced curling
EP2402391A1 (fr) * 2010-06-29 2012-01-04 Borealis AG Composition de polyéthylène bimodale pour articles moulés par injection
US20140287215A1 (en) * 2013-03-25 2014-09-25 Dow Global Technologies Llc Film having good barrier properties together with good physical characteristics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016165773A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053411A1 (fr) * 2019-09-20 2021-03-25 Sabic Global Technologies B.V. Polyéthylène haute densité à transparence accrue

Also Published As

Publication number Publication date
WO2016165773A1 (fr) 2016-10-20

Similar Documents

Publication Publication Date Title
EP3283566A1 (fr) Formulation
EP2578620B1 (fr) Mélange maître d'additif de résine
US8173735B2 (en) Resin additive master batch
US20070036960A1 (en) Film and methods of making film
JP2009508995A (ja) 成核剤或いは透明化剤を含むポリマー組成物
TWI725043B (zh) 樹脂添加劑組成物及使用其之合成樹脂組成物
JP4726380B2 (ja) ポリエチレンを主成分とする組成物および該組成物から加工される物品の製造方法
TW201510017A (zh) 透明化劑組成物及含有其所成的聚烯烴系樹脂組成物
US20220002519A1 (en) Additive composition and method for producing a polymer composition using the same
US20230143936A1 (en) Composition, thermoplastic resin composition using same, and molded article of same
JP6100766B2 (ja) 透明化剤組成物、樹脂組成物および成形品
JP2007063484A (ja) 新規なポリプロピレン樹脂組成物、該組成物を用いたシート又はフィルム成形体及びその製造方法
US20210301103A1 (en) Additive compositions and polymer compositions containing the same
EP2204408A1 (fr) Composition de résine polyoléfine
US8785529B2 (en) Nucleating agents for polyolefins based on metal salts
EP3006368B1 (fr) Matériau d'emballage à base de résine polyoléfine
CN115210313A (zh) 聚烯烃树脂用结晶成核剂组合物和包含所述结晶成核剂组合物的聚烯烃树脂组合物
TW202045520A (zh) 成核劑組成物、烯烴系樹脂組成物、其成形品及烯烴系樹脂組成物的製造方法
JP2002249673A (ja) 結晶性合成樹脂組成物

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

PUAG Search results despatched under rule 164(2) epc together with communication from examining division

Free format text: ORIGINAL CODE: 0009017

17Q First examination report despatched

Effective date: 20190318

B565 Issuance of search results under rule 164(2) epc

Effective date: 20190318

RIC1 Information provided on ipc code assigned before grant

Ipc: C08K 5/00 20060101ALI20190313BHEP

Ipc: C08L 23/06 20060101AFI20190313BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20211103